Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alcobra Ltd. (ADHD)

« Back to company index

ADHD Chatter Timeline

Stock Ticker for ADHD

Most Active Tweeters for ADHD

No tweets found

Recent Tweets for ADHD

Stock_News_Now @Stock_News_Now
$ADHD: New SEC Filing for ADHD: Form 6-K (No. 0001193805-18-001024): https://t.co/WpXNofjfc2
July 27th 2018, 4:07pm
confcalltran @confcalltran
Alcobra: Notice Of Annual And Extraordinary General Meeting Of Shareholders TO BE HELD ON AUGUS https://t.co/lfEx2PfBGj $ADHD
July 27th 2018, 4:07pm
confcalltran @confcalltran
Alcobra: Arcturus Therapeutics Announces Annual And Extraordinary General Meeting Of Shareholde https://t.co/bRwJKFP5JX $ADHD
July 20th 2018, 5:07pm
StockTexts @StockTexts
$ADHD Alcobra Ltd. SEC Filing: Form 6-K https://t.co/goD8n637m8
July 20th 2018, 5:07pm
StockTexts @StockTexts
$ADHD Alcobra Ltd. SEC Filing: Form CT ORDER https://t.co/CQAHcXN94D
July 19th 2018, 12:07pm
confcalltran @confcalltran
Alcobra: Arcturus Therapeutics Announces Results Of Extraordinary General Meeting Of Shareholde https://t.co/R9qsl7ywoH $ADHD
July 10th 2018, 4:07pm
StockTexts @StockTexts
$ADHD Alcobra Ltd. SEC Filing: Form 6-K https://t.co/uZxXwejQkX
July 10th 2018, 4:07pm
confcalltran @confcalltran
Annual and transition report of foreign private issuers [Sections 13 or 15(d)] https://t.co/paVSs1c22l $ADHD
July 10th 2018, 4:07pm
Stock_News_Now @Stock_News_Now
$ADHD: New SEC Filing for ADHD: Form 20-F/A (No. 0001564590-18-016705): https://t.co/eGoXLLOUoX
July 10th 2018, 4:07pm
xfinstocks2016 @xfinstocks2016
Alcobra Ltd. $ADHD Stock Live Analysis 10-18-2017 #nasdaq https://t.co/KtI0zhRnjO
July 8th 2018, 5:07pm
botpicks @botpicks
Should I Go Long or Short $ADHD ?
July 8th 2018, 2:07pm
StockTipRobot @StockTipRobot
Complex analysis suggests you should stop buying Alcobra Ltd. $ADHD #InvestingTip
June 30th 2018, 12:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.